The article compared UTI Nifty 50 Index Fund with ICICI Prudential Large Cap Fund (erstwhile Bluechip) and concluded that the ...

Caitlin Clark faced fresh criticism after a radio host claimed her WNBA stardom is fading and compared her rise to Jeremy Lin’s “Linsanity” run. After a few years from now, if someone asks the next ...

Introduction Early open fracture management aims to minimise the risk of complications. For the most severe open fracture wounds, multiple irrigation and debridement surgeries are required to overcome ...

This Pew Research Center analysis examines Americans’ views of Trump and the two major parties. Pew Research Center conducts research to help the public, media and decision-makers understand important ...

Welcome to From the Politics Desk, a daily newsletter that brings you the NBC News Politics team’s latest reporting and analysis from the White House, Capitol Hill and the campaign trail. Subscribe to ...

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more. You ...

For the first time in decades, net migration for the United States was likely negative in 2025, and the trend could continue amid President Donald Trump's aggressive immigration enforcement actions, ...

The first observer to catalog differences in star brightnesses was Greek astronomer Hipparchus. He created a catalog around 135 B.C.E. of roughly 850 stars divided into six ranges. He called the ...

The Netherlands registered 474 hours with negative electricity prices over the first eight months of 2025, according to figures from Dutch consultancy Stratergy. The figure surpasses the number of ...

A negative mindset is known to trigger or heighten stress and anxiety — and new research has revealed other trickle-down effects on mental and physical health. Researchers from Amen Clinics, a ...

De-escalated neoadjuvant taxane plus trastuzumab and pertuzumab with or without carboplatin in HER2-positive early breast cancer (neoCARHP): A multicentre, open-label, randomised, phase 3 trial.